Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.

The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...

HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...

Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch ...

Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolizatio ...

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...

Endologix LLC announced 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass ...

Gore & Associates announced that the FDA approved updated labeling for the Gore Excluder abdominal aortic aneurysm (AAA) ...

Reflow Medical, Inc. announced the enrollment of the first patient in the DEEPER CHALLENGE clinical trial, which is investigating e ...

StarMed America announced FDA 510(k) clearance for its radiofrequency ablation (RFA) devices for the treatment of thyroid ...